Literature DB >> 8536370

Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis.

J Highton1, B Carlisle, D G Palmer.   

Abstract

Data from a previous study suggested that peripheral blood monocytes in patients with rheumatoid arthritis (RA) may be activated. Therefore, in this study we sought further evidence of 'presynovial' activation of monocytes. Our results show that phenotypic changes are demonstrable in peripheral blood monocytes in patients with RA, including increased expression of CR3 (CD11b/CD18) and FcRI (CD64). However, changes are most extensive in synovial monocytes/macrophages and especially for HLA-DR and intercellular adhesion molecule-1 (ICAM-1) (CD54). We conclude that monocyte/macrophage activation is most evident within the joint, and that 'presynovial' changes occur but are of limited extent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536370      PMCID: PMC1553364          DOI: 10.1111/j.1365-2249.1995.tb03850.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Vascularity of the early subcutaneous nodule of rheumatoid arthritis.

Authors:  L SOKOLOFF; R T MCCLUSKEY; J J BUNIM
Journal:  AMA Arch Pathol       Date:  1953-06

2.  Stimulated mobilization of monocyte Mac-1 and p150,95 adhesion proteins from an intracellular vesicular compartment to the cell surface.

Authors:  L J Miller; D F Bainton; N Borregaard; T A Springer
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

3.  Cells of the monocyte-macrophage series in peripheral blood and synovial fluid in inflammatory arthritis. A preliminary study of cellular phenotype.

Authors:  J Highton; M Smith; J Bradley
Journal:  Scand J Rheumatol       Date:  1989       Impact factor: 3.641

4.  Immunological and immunohistochemical analysis of rheumatoid nodules.

Authors:  N Miyasaka; K Sato; K Yamamoto; M Goto; K Nishioka
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

5.  The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1.

Authors:  G J Dougherty; Y Selvendran; S Murdoch; D G Palmer; N Hogg
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

6.  Increased expression of p150,95 and CR3 leukocyte adhesion molecules by mononuclear phagocytes in rheumatoid synovial membranes. Comparison with osteoarthritic and normal synovial membranes.

Authors:  C A Allen; J Highton; D G Palmer
Journal:  Arthritis Rheum       Date:  1989-08

7.  A mononuclear phagocyte subset associated with cell necrosis in rheumatoid nodules: identification with monoclonal antibody 5.5.

Authors:  D G Palmer; N Hogg; C A Allen; J Highton; P A Hessian
Journal:  Clin Immunol Immunopathol       Date:  1987-10

8.  Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis.

Authors:  L Klareskog; U Forsum; A Scheynius; D Kabelitz; H Wigzell
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells.

Authors:  B Perussia; E T Dayton; R Lazarus; V Fanning; G Trinchieri
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  13 in total

1.  Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids.

Authors:  I Torsteinsdóttir; N G Arvidson; R Hällgren; L Håkansson
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

2.  Depletion of synovial macrophages in rheumatoid arthritis by an anti-FcgammaRI-calicheamicin immunoconjugate.

Authors:  J A G van Roon; J W J Bijlsma; J G J van de Winkel; F P J G Lafeber
Journal:  Ann Rheum Dis       Date:  2004-11-11       Impact factor: 19.103

3.  Evolution of the primary immune response to Histoplasma capsulatum in murine lung.

Authors:  J A Cain; G S Deepe
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease?

Authors:  Wolfgang Tillinger; Ruth Jilch; Thomas Waldhoer; Walter Reinisch; Wolfgang Junger
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

5.  FCGR3A-V158F polymorphism is a disease-specific pharmacogenetic marker for the treatment of psoriasis with Fc-containing TNFα inhibitors.

Authors:  E Mendrinou; A Patsatsi; E Zafiriou; D Papadopoulou; L Aggelou; C Sarri; Z Mamuris; A Kyriakou; D Sotiriadis; A Roussaki-Schulze; T Sarafidou; Y Vasilopoulos
Journal:  Pharmacogenomics J       Date:  2016-04-05       Impact factor: 3.550

6.  Evidence for somatic gene conversion and deletion in bipolar disorder, Crohn's disease, coronary artery disease, hypertension, rheumatoid arthritis, type-1 diabetes, and type-2 diabetes.

Authors:  Kenneth Andrew Ross
Journal:  BMC Med       Date:  2011-02-03       Impact factor: 8.775

Review 7.  Macrophages in rheumatoid arthritis.

Authors:  R W Kinne; R Bräuer; B Stuhlmüller; E Palombo-Kinne; G R Burmester
Journal:  Arthritis Res       Date:  2000-04-12

8.  The CD14+CD16+ inflammatory monocyte subset displays increased mitochondrial activity and effector function during acute Plasmodium vivax malaria.

Authors:  Lis R V Antonelli; Fabiana M S Leoratti; Pedro A C Costa; Bruno C Rocha; Suelen Q Diniz; Mauro S Tada; Dhelio B Pereira; Andrea Teixeira-Carvalho; Douglas T Golenbock; Ricardo Gonçalves; Ricardo T Gazzinelli
Journal:  PLoS Pathog       Date:  2014-09-18       Impact factor: 6.823

Review 9.  MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis.

Authors:  Stefano Alivernini; Elisa Gremese; Charles McSharry; Barbara Tolusso; Gianfranco Ferraccioli; Iain B McInnes; Mariola Kurowska-Stolarska
Journal:  Front Immunol       Date:  2018-01-05       Impact factor: 7.561

10.  Antibody induced CD4 down-modulation of T cells is site-specifically mediated by CD64(+) cells.

Authors:  Stephanie Vogel; Elena Grabski; Daniela Buschjäger; Frank Klawonn; Marius Döring; Junxi Wang; Erika Fletcher; Ingo Bechmann; Torsten Witte; Martin Durisin; Burkhart Schraven; Sara M Mangsbo; Kurt Schönfeld; Niklas Czeloth; Ulrich Kalinke
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.